<DOC>
	<DOCNO>NCT02873104</DOCNO>
	<brief_summary>To evaluate safety efficacy Cutera truSculpt radiofrequency device circumferential reduction .</brief_summary>
	<brief_title>Pivotal Study truSculpt Radiofrequency Device Circumferential Reduction</brief_title>
	<detailed_description>The objective study evaluate efficacy safety treatment Cutera truSculpt RF device circumferential reduction abdominal flank region .</detailed_description>
	<criteria>Female Male , 24 60 year age ( inclusive ) . Fitzpatrick Skin Type I VI . Has visible fat bulge abdomen palpable fat pocket superior iliac crest locate bilaterally low back flank region Has Body Mass Index ( BMI ) ≥ 20 ≤ 30 Nonsmoking least 6 month willing refrain smoke duration study . Subject must agree undergo procedure ( ) abdominal flank region study period . Subject must able read , understand sign Informed Consent Form . Subject must adhere followup schedule study instruction . Subject must adhere diet and/or exercise routine throughout study , agree maintain weight throughout study , within 5 % baseline weight measurement . Willing digital photograph take treatment area agree use photograph presentation , educational marketing purpose . Postmenopausal surgically sterilize , use medically acceptable form birth control least 3 month prior enrollment entire course study , plan become pregnant . Participation clinical trial another device drug within 6 month study participation , study period . Any type prior cosmetic treatment target area within 12 month study participation e.g. , radiofrequency , cryolysis lightbased treatment . Any prior invasive cosmetic surgery target area , liposuction . Currently take medication supplement weightloss metabolism support/enhancement history take medication supplement within 3 month . Has pacemaker , internal defibrillator , implantable cardioverterdefibrillator , nerve stimulator implant , cochlear implant electronically , magnetically mechanically activated implant . Has metal implant ( ) within body , surgical clip , plat screw , intrauterine device ( IUD ) , artificial heart valves artificial joint . Significant concurrent illness , diabetes mellitus , cardiovascular disease , peripheral vascular disease pertinent neurological disorder . Diagnosed document immune system disorder . History disease condition could impair wound heal . History diseases stimulate heat , recurrent herpes zoster treatment area , unless treatment conduct follow prophylactic regimen . History keloid formation , hypertrophic scar abnormal/delayed wound heal . Infection , dermatitis , rash skin abnormality target area . Currently undergo systemic chemotherapy radiation treatment cancer , history treatment target area within 3 month study participation . Pregnant currently breastfeed . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>